FLGTFulgent Genetics, Inc.
Is it safe?
Caution warranted: heavy debt (BB) and big price swings.
Net cash, but unprofitable, speculative. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -92% · now 32% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can FLGT take a bad year?
Fulgent Genetics, Inc. holds $257M more cash than debt, and is burning $26M a quarter, about 2.5 years of cover.
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Cash runway
- 2.5 years
Cash runway · burning $26M a quarter at the current rate
- Annualised volatility
- 54%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $482K
- Cash and short-term investments
- $257M
- Net cash
- $257M
- EBITDA, trailing twelve months
- −$101M
- Operating profit, trailing twelve months
- −$122M
- Debt / equity
- 0.00×
- Annualised volatilitytwo years of daily moves
- 54%
- Worst drawdown on file
- −93%
- Below its 52-week high
- 32%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Diagnostics & Research
Ranks #14 of 21 by RyuScore